Tags

Type your tag names separated by a space and hit enter

Transurethral seminal vesiculoscopy acts as a therapeutic investigation for intractable hemospermia: Step-by-step illustrations and single-surgeon experience.
Int J Urol. 2018 06; 25(6):589-595.IJ

Abstract

OBJECTIVE

To describe the methodology of transurethral seminal vesiculoscopy and the anatomy of the seminal tract, and to report a single-surgeon experience with this procedure.

METHODS

A total of 38 consecutive patients with intractable macroscopic hemospermia were enrolled from January 2010 to July 2016. A 6/7.5-Fr semirigid ureteroscope was used to enter the seminal tract by one of these two approaches: through either a trans-ejaculatory duct opening or a trans-utricle fenestration. Patient characteristics and their preoperative and postoperative measurements were analyzed retrospectively.

RESULTS

The success rate of transurethral seminal vesiculoscopy was 92.1%, whereas the approaching method in most patients was the trans-utricle fenestration (88.89%). A total of 34 (94.4%) transurethral seminal vesiculoscopy inspections ended with complete remission, even though nearly half of them (47.2%) only disclosed negative perioperative findings. The median period to complete remission was 4 weeks (interquartile range 4-6 weeks) after the procedure. Four patients had recurrent hemospermia, and the median time to recurrence was 21.5 (range 13-48.5) months.

CONCLUSIONS

Transurethral seminal vesiculoscopy is a valuable diagnostic tool for intractable hemospermia, and also plays a therapeutic role by blocking the vicious cycle of stasis, calculi and seminal vesiculitis. More familiarity of the anatomy and enough practice would make the learning curve less steep.

Authors+Show Affiliations

Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.Division of Urology, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

29664136

Citation

Hu, Ju-Chuan, and Chuan-Shu Chen. "Transurethral Seminal Vesiculoscopy Acts as a Therapeutic Investigation for Intractable Hemospermia: Step-by-step Illustrations and Single-surgeon Experience." International Journal of Urology : Official Journal of the Japanese Urological Association, vol. 25, no. 6, 2018, pp. 589-595.
Hu JC, Chen CS. Transurethral seminal vesiculoscopy acts as a therapeutic investigation for intractable hemospermia: Step-by-step illustrations and single-surgeon experience. Int J Urol. 2018;25(6):589-595.
Hu, J. C., & Chen, C. S. (2018). Transurethral seminal vesiculoscopy acts as a therapeutic investigation for intractable hemospermia: Step-by-step illustrations and single-surgeon experience. International Journal of Urology : Official Journal of the Japanese Urological Association, 25(6), 589-595. https://doi.org/10.1111/iju.13569
Hu JC, Chen CS. Transurethral Seminal Vesiculoscopy Acts as a Therapeutic Investigation for Intractable Hemospermia: Step-by-step Illustrations and Single-surgeon Experience. Int J Urol. 2018;25(6):589-595. PubMed PMID: 29664136.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Transurethral seminal vesiculoscopy acts as a therapeutic investigation for intractable hemospermia: Step-by-step illustrations and single-surgeon experience. AU - Hu,Ju-Chuan, AU - Chen,Chuan-Shu, Y1 - 2018/04/17/ PY - 2017/12/21/received PY - 2018/02/22/accepted PY - 2018/4/18/pubmed PY - 2019/5/23/medline PY - 2018/4/18/entrez KW - diagnosis KW - hemospermia KW - therapy KW - transurethral seminal vesiculoscopy SP - 589 EP - 595 JF - International journal of urology : official journal of the Japanese Urological Association JO - Int J Urol VL - 25 IS - 6 N2 - OBJECTIVE: To describe the methodology of transurethral seminal vesiculoscopy and the anatomy of the seminal tract, and to report a single-surgeon experience with this procedure. METHODS: A total of 38 consecutive patients with intractable macroscopic hemospermia were enrolled from January 2010 to July 2016. A 6/7.5-Fr semirigid ureteroscope was used to enter the seminal tract by one of these two approaches: through either a trans-ejaculatory duct opening or a trans-utricle fenestration. Patient characteristics and their preoperative and postoperative measurements were analyzed retrospectively. RESULTS: The success rate of transurethral seminal vesiculoscopy was 92.1%, whereas the approaching method in most patients was the trans-utricle fenestration (88.89%). A total of 34 (94.4%) transurethral seminal vesiculoscopy inspections ended with complete remission, even though nearly half of them (47.2%) only disclosed negative perioperative findings. The median period to complete remission was 4 weeks (interquartile range 4-6 weeks) after the procedure. Four patients had recurrent hemospermia, and the median time to recurrence was 21.5 (range 13-48.5) months. CONCLUSIONS: Transurethral seminal vesiculoscopy is a valuable diagnostic tool for intractable hemospermia, and also plays a therapeutic role by blocking the vicious cycle of stasis, calculi and seminal vesiculitis. More familiarity of the anatomy and enough practice would make the learning curve less steep. SN - 1442-2042 UR - https://www.unboundmedicine.com/medline/citation/29664136/Transurethral_seminal_vesiculoscopy_acts_as_a_therapeutic_investigation_for_intractable_hemospermia:_Step_by_step_illustrations_and_single_surgeon_experience_ L2 - https://doi.org/10.1111/iju.13569 DB - PRIME DP - Unbound Medicine ER -